1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with deamino arginine vasopressin in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (deamino arginine vasopressin) | Trials (deamino arginine vasopressin) | Recent Studies (post-2010) (deamino arginine vasopressin) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 4,396 | 516 | 1,016 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aye, MT; Ganz, PR; Hashemi, S; Palmer, DS | 1 |
| Despotis, GJ; Filos, KS; Goodnough, LT; Joist, JH; Levine, V; Santoro, SA; Spitznagel, E | 1 |
| Aydinok, Y; Hüseyinof, A; Kavakli, K; Nisli, G; Polat, A | 1 |
| Aydinok, Y; Coker, I; Hüseyinov, A; Kavakli, K; Nisli, G | 1 |
4 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and deamino arginine vasopressin
| Article | Year |
|---|---|
Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cells, Cultured; Cytokines; Deamino Arginine Vasopressin; Dioxolanes; Endothelium, Vascular; Epoprostenol; Humans; Kinetics; Monocytes; Platelet Activating Factor; Prostaglandins; von Willebrand Factor | 1993 |
Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients.
Topics: Aged; Blood Loss, Surgical; Cardiac Surgical Procedures; Deamino Arginine Vasopressin; Evaluation Studies as Topic; Female; Hemostasis; Humans; Male; Middle Aged; Platelet Activating Factor; Platelet Transfusion; Postoperative Complications; Preoperative Care; Renal Agents; Whole Blood Coagulation Time | 1996 |
Plasma platelet-activating factor (PAF) levels and desmopressin response in children with hemophilia A and von Willebrand's disease.
Topics: Adolescent; Adult; Child; Child, Preschool; Deamino Arginine Vasopressin; Hemophilia A; Hemostatics; Humans; Platelet Activating Factor; von Willebrand Diseases | 1999 |
Intraleucocyte platelet-activating factor levels in desmopressin-treated patients with haemophilia A and von Willebrand disease.
Topics: Adolescent; Adult; Calcimycin; Child; Child, Preschool; Deamino Arginine Vasopressin; Female; Hemophilia A; Hemostatics; Humans; Ionophores; Leukocytes; Male; Platelet Activating Factor; Treatment Outcome; von Willebrand Diseases | 2001 |